Dynamk Capital
Overview
Venture and growth equity fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma. We provide the fuel, resources and capital life science entrepreneurs need
Investment Focus
- Innovative life science technologies
- Early-stage companies
- Disruptive tools and services for biopharmaceutical industry
Portfolio Companies
Reach Dynamk Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Dynamk Capital
What sectors does Dynamk Capital invest in?
Dynamk Capital invests in Artificial Intelligence, Life Sciences, Pharmaceuticals, Medical Devices, Bioinformatics and Machine Learning, and is based in New York, United States. Dynamk Capital is listed as a vc in the ConnectSafely investor database.
What stage does Dynamk Capital invest at?
Dynamk Capital backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 500K - 700K.
Which regions does Dynamk Capital invest in?
Dynamk Capital invests across United States.
What companies has Dynamk Capital invested in?
Dynamk Capital's portfolio includes Envisagenics, RoosterBio, Alpenglow Biosciences, Virica Biotech, Vectron Biosolutions, Curibio, Lucid Scientific and CellFE Biotech.
How do I contact Dynamk Capital?
Dynamk Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
